Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets
Abstract Background Hepatocellular (HCC) and cholangiocellular carcinomas (CCC) display an exceptionally poor prognosis. Especially for advanced disease no efficient standard therapy is currently available. Recently, somatostatin analogs have been evaluated for the treatment of HCC, however, with co...
Main Authors: | Daniel Kaemmerer, Robin Schindler, Franziska Mußbach, Uta Dahmen, Annelore Altendorf-Hofmann, Olaf Dirsch, Jörg Sänger, Stefan Schulz, Amelie Lupp |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-12-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-017-3911-3 |
Similar Items
-
Comparative evaluation of somatostatin and CXCR4 receptor expression in different types of thyroid carcinoma using well-characterised monoclonal antibodies
by: Czajkowski, M., et al.
Published: (2022) -
Somatostatin Receptors and Chemokine Receptor CXCR4 in Lymphomas: A Histopathological Review of Six Lymphoma Subtypes
by: Tiina Juntikka, et al.
Published: (2021-07-01) -
Intrahepatic cholangiocellular carcinoma (review)
by: Yu O Zharikov, et al.
Published: (2015-06-01) -
EFFICIENCY OF ULTRASOUND STUDY IN THE DIAGNOSIS OF CHOLANGIOCELLULAR CARCINOMA
by: T. Yu. Danzanova, et al.
Published: (2016-02-01) -
Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma
by: Irina Chifu, et al.
Published: (2020-11-01)